CartX Revenue and Competitors
Estimated Revenue & Valuation
- CartX's estimated annual revenue is currently $1.7M per year.
- CartX's estimated revenue per employee is $87,000
Employee Data
- CartX has 19 Employees.
- CartX grew their employee count by 111% last year.
CartX's People
| Name | Title | Email/Phone |
|---|
CartX Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $60M | 331 | 24% | N/A | N/A |
#2 | $5.3M | 46 | -6% | N/A | N/A |
#3 | $36.8M | 236 | -3% | $46.9M | N/A |
#4 | $15.1M | 104 | 4% | N/A | N/A |
#5 | $1.4M | 16 | -6% | N/A | N/A |
#6 | $1.4M | 16 | -6% | N/A | N/A |
#7 | $3.5M | 30 | -12% | N/A | N/A |
#8 | $146M | 719 | 6% | N/A | N/A |
#9 | $99.7M | 550 | -1% | N/A | N/A |
#10 | $12.9M | 89 | -3% | $3.5M | N/A |
What Is CartX?
CartX's mission is to allow anyone to create a store and start selling online. Anyone can have an online business. We remove infrastructure complexity so you can focus on what you do best: build your brand. Now providing thousands of customers with the highest converting, friction-less, e-commerce experience in Brazil. CartX is the go-to solution to increase sales and order average value.
keywords:N/AN/A
Total Funding
19
Number of Employees
$1.7M
Revenue (est)
111%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CartX News
2022-03-22 - Pathogen-specific humoral immunity and infections in BCMA-directed chimeric
antigen receptor T-cell therapy recipients with multiple myeloma
BACKGROUND: Chimeric antigen receptor (CAR) T cells targeting B-cell maturation antigen (BCMA-CARTx) are an emerging treatment for relapsed...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.7M | 19 | 0% | N/A |
#2 | $1.2M | 19 | 0% | N/A |
#3 | $1.1M | 19 | -14% | N/A |
#4 | $3.7M | 19 | -5% | N/A |
#5 | $1.7M | 19 | N/A | N/A |
